Facco Francesca L, Parker Corette B, Reddy Uma M, Silver Robert M, Louis Judette M, Basner Robert C, Chung Judith H, Schubert Frank P, Pien Grace W, Redline Susan, Mobley Daniel R, Koch Matthew A, Simhan Hyagriv N, Nhan-Chang Chia-Ling, Parry Samuel, Grobman William A, Haas David M, Wing Deborah A, Mercer Brian M, Saade George R, Zee Phyllis C
Department of Obstetrics and Gynecology, Magee-Womens Research Institute & Foundation, University of Pittsburgh School of Medicine, Pittsburgh, PA.
RTI International, Research Triangle Park, NC.
Am J Obstet Gynecol. 2015 Apr;212(4):542.e1-127. doi: 10.1016/j.ajog.2015.01.021. Epub 2015 Mar 4.
The objective of the Sleep Disordered Breathing substudy of the Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-be (nuMoM2b) is to determine whether sleep disordered breathing during pregnancy is a risk factor for adverse pregnancy outcomes.
NuMoM2b is a prospective cohort study of 10,037 nulliparous women with singleton gestations that was conducted across 8 sites with a central Data Coordinating and Analysis Center. The Sleep Disordered Breathing substudy recruited 3702 women from the cohort to undergo objective, overnight in-home assessments of sleep disordered breathing. A standardized level 3 home sleep test was performed between 6(0)-15(0) weeks' gestation (visit 1) and again between 22(0)-31(0) weeks' gestation (visit 3). Scoring of tests was conducted by a central Sleep Reading Center. Participants and their health care providers were notified if test results met "urgent referral" criteria that were based on threshold levels of apnea hypopnea indices, oxygen saturation levels, or electrocardiogram abnormalities but were not notified of test results otherwise. The primary pregnancy outcomes to be analyzed in relation to maternal sleep disordered breathing are preeclampsia, gestational hypertension, gestational diabetes mellitus, fetal growth restriction, and preterm birth.
Objective data were obtained at visit 1 on 3261 women, which was 88.1% of the studies that were attempted and at visit 3 on 2511 women, which was 87.6% of the studies that were attempted. Basic characteristics of the substudy cohort are reported in this methods article.
The substudy was designed to address important questions regarding the relationship of sleep-disordered breathing on the risk of preeclampsia and other outcomes of relevance to maternal and child health.
未生育孕妇妊娠结局研究监测准妈妈项目(nuMoM2b)中的睡眠呼吸障碍子研究旨在确定孕期睡眠呼吸障碍是否为不良妊娠结局的危险因素。
nuMoM2b是一项对10,037名单胎妊娠未生育女性进行的前瞻性队列研究,在8个地点开展,设有一个中央数据协调与分析中心。睡眠呼吸障碍子研究从该队列中招募了3702名女性,对其进行睡眠呼吸障碍的客观居家过夜评估。在妊娠6(0)-15(0)周(第1次访视)和22(0)-31(0)周(第3次访视)之间分别进行一次标准化的3级家庭睡眠测试。测试评分由一个中央睡眠阅读中心进行。如果测试结果符合基于呼吸暂停低通气指数、血氧饱和度水平或心电图异常阈值水平的“紧急转诊”标准,会通知参与者及其医疗服务提供者,否则不通知测试结果。与母亲睡眠呼吸障碍相关的主要妊娠结局包括子痫前期、妊娠期高血压、妊娠期糖尿病、胎儿生长受限和早产。
在第1次访视时,对3261名女性获取了客观数据,占尝试研究对象的88.1%;在第3次访视时,对2511名女性获取了客观数据,占尝试研究对象的87.6%。本方法文章报告了子研究队列的基本特征。
该子研究旨在解决关于睡眠呼吸障碍与子痫前期风险以及其他与母婴健康相关结局之间关系的重要问题。